Mpox Epidemiology and Risk Factors, Nigeria, 2022
Dimie Ogoina
, Mahmmod Muazu Dalhat, Ballah Akawu Denue, Mildred Okowa, Nneka Marian Chika-Igwenyi, Sebastine Oseghae Oiwoh, Ekaete Alice Tobin, Hakeem Abiola Yusuff, Anastacia Okwudili Ojimba, Umenzekwe Chukwudi Christian, John-Tunde Aremu, Simji Samuel Gomerep, Kambai Lalus Habila, Sati Klein Awang, Olukemi Adekanmbi, Michael Iroezindu, Asukwo Onukak, Olanrewaju Falodun, Mogaji Sunday, Simon Mafuka Johnson, Abimbola Olaitan, Chizaram Onyeaghala, Datonye Alasia, Juliet Mmerem, Uche Unigwe, Vivian Kwaghe, Mukhtar Abdulmajid Adeiza, and
on behalf of Nigerian Infectious Diseases Society (NIDS) mpox study group1
Author affiliations: Niger Delta University/Niger Delta University Teaching Hospital, Bayelsa, Nigeria (D. Ogoina); Infectious Diseases Control Centre, Kaduna State, Nigeria (M.M. Dalhat); University of Maiduguri, Maiduguri, Nigeria (B.A. Denue); Ministry of Health, Asaba, Nigeria (M. Okowa); Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria (N.M. Chika-Igwenyi); Irrua Specialist Teaching Hospital, Irrua, Nigeria (S. Oiwoh, E.A. Tobin); Ministry of Health, Abeokuta, Nigeria (H.A. Yusuff); Federal Medical Centre, Asaba (A.O. Ojimba); Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria. (U.C. Christian); Federal Teaching Hospital, Gombe, Nigeria (J.T. Aremu); Jos University Teaching hospital/University of Jos, Jos, Nigeria (S.S. Gomerep); Kaduna State Emergency Medical Services and Ambulance System, Kaduna, Nigeria (K.L. Habila); Modibo Adamawa University Teaching Hospital, Yola, Nigeria (S.K. Awang); University of Ibadan College of Medicine, Ibadan, Nigeria (O. Adekanmbi); University of Nigeria Teaching Hospital, Enugu, Nigeria (M. Iroezindu, J Mmerem, U. Unigwe); University of Uyo, Uyo, Nigeria (A. Onukak); National Hospital Abuja, Abuja, Nigeria (O. Falodun); Federal Medical Centre Ebute-Metta, Lagos, Nigeria (M. Sunday); Federal University Teaching Hospital, Imo, Nigeria (S.M. Johnson); Olabisi Onabanjo University Teaching Hospital, Sagamu, Nigeria (A. Olaitan); University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria (C. Onyeaghala, D. Alasia); University of Abuja Teaching Hospital, Gwagalada, Nigeria (V. Kwaghe); Ahmadu Bello University Teaching Hospital, Zaria, Nigeria (M.A. Adeiza)
Main Article
Figure
Figure. Geographic distribution of sites in Nigeria participating in a study of epidemiology and risk factors for laboratory-confirmed mpox during the mpox outbreak, Nigeria, 2022. A total of 265 study participants were enrolled from all geopolitical zones of the country, across 23 states and the Federal Capital Territory in Nigeria.
Main Article
Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.